| Question 1: Which clinical trial networks comprise National Clinical Trials Network (NCTN):
|
| Reference: | Literature: https://www.cancer.gov/research/areas/clinical-trials/nctn
|
| Choice A: | ECOG-ACRIN, RTOG, Alliance, COG |
| Choice B: | ECOG, SWOG, RTOG, ACRIN, COG |
| Choice C: | Alliance, SWOG, ECOG-ACRIN, NRG Oncology, COG |
| Choice D: | Alliance, SWOG, RTOG, NRG Oncology, COG |
| Question 2: Which of the following organization is unrelated to NCI clinical trial quality assurance?
|
| Reference: | www.irocqa.org
www.nrgoncology.org
|
| Choice A: | CIRO. |
| Choice B: | IROC. |
| Choice C: | CORI. |
| Question 3: Which of the following statement is true regarding the roles of medical physicist in clinical trials?
|
| Reference: | https://www.nrgoncology.org/Scientific-Program/Center-for-Innovation-in-Radiation-Oncology
|
| Choice A: | Assist with clinical trial concept. |
| Choice B: | Assume responsibility as medical physics principal investigator of an active protocol. |
| Choice C: | Ensure data quality from treatment planning and delivery. |
| Choice D: | All of the above. |
| Question 4: Can standard clinical imaging procedures with limited or no formal quantification and with variations in acquisition, display, and interpretation methods achieve the medical diagnostic purposes?
|
| Reference: | FDA CDER, “Clinical Trial Imaging Endpoint Process Standards, Standards Guidance for Industry. DRAFT GUIDANCE” Version 1. March. 2015. |
| Choice A: | Yes. |
| Choice B: | No. |
| Choice C: | Only if FDA approved. |
| Choice D: | Only if the imaging facility is clinically accredited. |
| Question 5: Are standard clinical imaging procedures suitable for clinical trials using imaging? |
| Reference: | FDA CDER, “Clinical Trial Imaging Endpoint Process Standards, Standards Guidance for Industry. DRAFT GUIDANCE” Version 1. March. 2015.
|
| Choice A: | Yes. |
| Choice B: | No. |
| Choice C: | It depends on the specific goals of the trial. |
| Question 6: When a medical physicist is asked to establish credentialing for an institution to participate national clinical trials through NRG Oncology, what is the first thing he or she needs to do? |
| Reference: | https://www.nrgoncology.org/RT-and-Imaging-Credentialing |
| Choice A: | Ask the president of the hospital. |
| Choice B: | Ask the head of the IRB. |
| Choice C: | Search the website for NRG Oncology. |
| Choice D: | Search the AAPM official website. |
| Choice E: | Search the ASTRO official website. |
